HTGC Hercules Capital, Inc.
Company Analysis
Latest News
Hercules Capital Gains BlackRock Stake, Driven by Robust Portfolio Performance
BlackRock Inc. acquired a new stake in Hercules Capital, Inc. (NYSE:HTGC) according to a September 4, 2026, 13F filing. The asset manager purchased 924,105...
Hercules Capital's second quarter NII meets estimates at $0.50/share while NAV increases to $12.15.
Hercules Capital reported second quarter total investment income of $149.1 million, an increase of 8.5% year-over-year, and Net Investment Income (NII) of...
Hercules Capital, Inc. Q2 2026 Earnings Preview: What Analysts Expect on July 30, 2026
Hercules Capital is expected to report Q2 2026 total investment income of approximately $148.9 million (+8.3% YoY) and Net Investment Income (NII) of $0.50 per...
Hercules Capital Completes $325 Million Public Offering of 6.300% Notes Due 2031
Hercules Capital, Inc. announced the closing of a public offering of $325 million in aggregate principal amount of 6.300% unsecured notes. The company intends...
Hercules Capital's second quarter 2026 NAV per share grew up to 2.5% on strong new loan funding.
Hercules Capital released preliminary second quarter 2026 results, highlighting an increase in Net Asset Value (NAV) per share and strong net investment...
Hercules Capital Shareholders Approve All Proposals at 2026 Annual Meeting
Hercules Capital, Inc. announced the results of its 2026 Annual Meeting of Stockholders held on June 18, 2026. Shareholders approved all six proposals,...
Hercules Capital Increases Dyne Loan to $400M, Supporting Two Drug Launches
Hercules Capital (HTGC) amended its senior secured term loan with Dyne Therapeutics (Nasdaq: DYN). The agreement expands Dyne's total borrowing capacity to...